Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

1.17
Delayed Data
As of Sep 22
 -0.05 / -4.10%
Today’s Change
0.52
Today|||52-Week Range
3.15
-44.29%
Year-to-Date
No recent news for Ocera Therapeutics Inc.

Today’s Trading

Previous close1.22
Today’s open1.20
Day’s range1.10 - 1.23
Volume544,498
Average volume (3 months)195,045
Market cap$31.0M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)+31.15%
Earnings growth (next 5 years)--
Revenue growth (last year)+357.89%
P/E ratioNM
Price/Sales75.72
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...+0.03+4.00%
CAPRCapricor Therapeutic...+0.14+7.00%
SNOASonoma Pharmaceutica...-0.04-0.74%
DFFNDiffusion Pharmaceut...-0.16-8.84%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$609.0K
Annual profit (last year)-$26.9M
Net profit margin-4,416.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Linda S. Grais
Chief Financial &
Principal Accounting Officer
Michael Byrnes
Corporate headquarters
Palo Alto, California

Forecasts